𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Development of a validated HPLC method for the determination of four 1,4-benzodiazepines in human biological fluids

✍ Scribed by Victoria F. Samanidou; Anastasia P. Pechlivanidou; Ioannis N. Papadoyannis


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
488 KB
Volume
30
Category
Article
ISSN
1615-9306

No coin nor oath required. For personal study only.

✦ Synopsis


A simple and sensitive HPLC method was developed and validated for the determination of four frequently prescribed 1,4-benzodiazepines: alprazolam (ALP), bromazepam (BRZ), diazepam (DZP), and flunitrazepam (FNZ). Separation was achieved on an Inertsil C8 analytical (250 mm x 4 mm, 5 microm) column, after selective extraction of benzodiazepine drugs from biological matrices by means of SPE. Isocratic elution was performed with a mobile phase consisting of CH3COONH4, 0.05 M CH3OH, and CH3CN (33:57:10 by volume). Quantification was performed at 240 nm with mefenamic acid (6 ng/microL) as the internal standard. DSC-18 Supelco cartridges provided high absolute recoveries (81-115%). The developed method was fully validated in terms of selectivity, linearity, accuracy, precision, stability, and sensitivity. Repeatability (n = 8) and between-day precision (n = 8) revealed RSD <12%. Recoveries from biological samples ranged from 81.2 to 115%. The detection limit of the method was calculated as 3.3-10.2 ng in blood plasma and 2.6-12.6 ng in urine for 20 microL injection volume. The method was applied to spiked biological matrices. Moreover, the method was applied to real samples of urine after an oral administration.


πŸ“œ SIMILAR VOLUMES


Development of a CE method for the deter
✍ Filippo Carlucci; Maurizio Anzini; Michele Rovini; Dario Cattaneo; Simona Merlin πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 292 KB πŸ‘ 1 views

## Abstract Mycophenolate mofetil (MMF) is a widely used drug for the maintenance of immunosuppressive therapy in renal‐transplant recipients. MMF is rapidly metabolized __in vivo__ to mycophenolic acid (MPA), a reversible, noncompetitive inhibitor of inosine monophosphate dehydrogenase, which repr